CLINICAL_TRIALS
trial_result
· 2022-03-18
Clinical Trial Update: Brexpiprazole in Borderline Personality Disorder [Phase 2]
Summary
Phase 2 trial update for brexpiprazole in borderline personality disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Borderline Personality Disorder | Phase 2 | Status: COMPLETED | Results posted: 2022-03-18